Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Genetics
Genetics: Discovering the Unknown in Breast Cancer
BY BRIELLE BENYON
All Patients With GI Cancers Should Undergo NGS
BY TANIOS S. BEKAII-SAAB, MD
Biomarkers Predict Osteosarcoma Treatment Response
BY ELLIE LEICK
Expert Talks Liquid Biopsies, Molecular Testing in Lung Cancer
BY ELLIE LEICK
Genetic Testing and Inherited Increased Risk of Cancer
BY CANCER
CARE
New Agents Show Promise in Treating Patients with IDH1-Mutant Low-Grade Glioma
BY GINA COLUMBUS
Next-Generation Sequencing Sets Sights On Rare Mutations in Lung Cancer
BY ELLIE LEICK
Searching for Prognostic Markers in Patients with Osteosarcoma
BY ELHAM NASRI, MD
New Pathway Emerges as A Favorable Target in CRC
BY CAROLINE SEYMOUR
Additional Therapeutic Options for Patients With ALK+ and ROS1+ Lung Cancer Emerge
BY JESSICA HERGERT
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.